Jing et al. show that a drug screen using iPSC-derived hepatocytes that harbor a mutation in the DGUOK gene leads to the identification of potential treatments for mtDNA depletion syndromes. This evidence concerns the gene DGUOK and mitochondrial DNA depletion syndrome.